FOS and myocardial infarction: For example, a PMO-TSB targeting the miR-101a-3p binding site on XIST could restore miR-101a-3p availability to suppress FOS, thereby reducing cardiomyocyte apoptosis following myocardial infarction (Lin et al., 2020).